These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36208049)

  • 1. Effects of probiotics on gastric microbiota and its precombination with quadruple regimen for Helicobacter pylori eradication.
    Wu Y; Dong XY; Zhou XZ; Li ZS; Du YQ
    J Dig Dis; 2022 Aug; 23(8-9):462-472. PubMed ID: 36208049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
    Poonyam P; Chotivitayatarakorn P; Vilaichone RK
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults.
    Yuan Z; Xiao S; Li S; Suo B; Wang Y; Meng L; Liu Z; Yin Z; Xue Y; Zhou L
    Helicobacter; 2021 Dec; 26(6):e12848. PubMed ID: 34448282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics modulate gastrointestinal microbiota after
    He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
    Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
    Zagari RM; Romiti A; Ierardi E; Gravina AG; Panarese A; Grande G; Savarino E; Maconi G; Stasi E; Eusebi LH; Farinati F; Conigliaro R; Bazzoli F; Romano M
    Helicobacter; 2018 Aug; 23(4):e12502. PubMed ID: 29924430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
    Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metagenomic Changes of Gut Microbiota following Treatment of
    Dore MP; Sau R; Niolu C; Abbondio M; Tanca A; Bibbò S; Loria M; Pes GM; Uzzau S
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates.
    Viazis N; Argyriou K; Kotzampassi K; Christodoulou DK; Apostolopoulos P; Georgopoulos SD; Liatsos C; Giouleme O; Koustenis K; Veretanos C; Stogiannou D; Moutzoukis M; Poutakidis C; Mylonas II; Tseti I; Mantzaris GJ
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35276991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and safety of
    Niu Y; Li J; Qian H; Liang C; Shi X; Bu S
    Front Immunol; 2024; 15():1450414. PubMed ID: 39234246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial.
    Chen MJ; Chen CC; Huang YC; Tseng CC; Hsu JT; Lin YF; Fang YJ; Wu MS; Liou JM;
    Helicobacter; 2021 Dec; 26(6):e12857. PubMed ID: 34708471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gastric microbiota on quadruple
    Niu ZY; Li SZ; Shi YY; Xue Y
    World J Gastroenterol; 2021 Jul; 27(25):3913-3924. PubMed ID: 34321854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection.
    Liu A; Wang Y; Song Y; Du Y
    Saudi J Gastroenterol; 2020; 26(2):78-83. PubMed ID: 32295932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication].
    Kwon S; Lee DH; Kang JB; Kim N; Park YS; Shin CM; Yoon H; Choi YJ
    Korean J Gastroenterol; 2018 Apr; 71(4):196-203. PubMed ID: 29684968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
    Chen J; Zhang Y; Min H; Zhi J; Ma S; Dong H; Yan J; Chi X; Zhang X; Yang Y
    Helicobacter; 2024; 29(2):e13077. PubMed ID: 38682268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of different timing of
    He CX; Kong FT; Liang F; Wang KX; Li H; Liu YL; Zhao W; Zhou PP; Kong FL
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1731-1734. PubMed ID: 31216821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of two kinds of probiotics combined with bismuth quadruple therapy for
    Zhu XY; Du J; Zhao WJ; Wu J; Zhao LW; Meng X; Yang L; Jiao L; Ma H
    Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(28):2246-2249. PubMed ID: 30078279
    [No Abstract]   [Full Text] [Related]  

  • 18. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
    Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
    World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial.
    He XJ; Zeng XP; Jiang CS; Liu G; Li DZ; Wang W
    Arab J Gastroenterol; 2021 Mar; 22(1):47-51. PubMed ID: 33551347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea.
    Yoon K; Kim N; Lee JW; Yoon H; Shin CM; Park YS; Lee DH
    Helicobacter; 2020 Jun; 25(3):e12685. PubMed ID: 32141173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.